Glycopyrrolate Injection 0.2 mg/mL Single-Dose Vials 1 mL x 25/Tray by Somerset (RX)

Glycopyrrolate Injection 0.2 mg per 1 mL Single-Dose Vials are primarily used as an antimuscarinic agent to reduce saliva, gastric, and respiratory secretions during surgery. They help prevent bradycardia, counteract muscarinic effects from other medications, and are often administered preoperatively to enhance anesthesia. Glycopyrrolate also aids in the management of peptic ulcers by reducing stomach acid secretion.

Introducing Glycopyrrolate Injection 0.2 mg per 1 mL Single-Dose Vials by Somerset Pharma, a high-quality anticholinergic medication designed to meet your medical needs. This product is meticulously formulated and packaged to ensure optimal efficacy, safety, and convenience. Ideal for healthcare professionals, our Glycopyrrolate Injection is utilized in pre-operative settings to reduce salivary, tracheobronchial, and pharyngeal secretions, as well as to maintain stable heart rates during surgery.

Product Details and Features:

Concentration: Each single-dose vial contains 0.2 mg of glycopyrrolate per 1 mL of solution.
Packaging: 1 mL single-dose vials, packaged 25 per tray, offering ease of use and reduced waste.
Sterility and Safety Package: Sterile and non-pyrogenic solution, ensuring the highest standards of safety.
Optimal Efficacy: Rapid onset of action typically within minutes, providing timely therapeutic outcomes.
Reliable Formulation: Manufactured under stringent quality controls, guaranteeing consistent performance and purity.

Mechanism of Action:

Glycopyrrolate functions as an antimuscarinic agent. It works by competitively inhibiting the action of acetylcholine on autonomic effectors innervated by postganglionic cholinergic nerves. By blocking acetylcholine, glycopyrrolate effectively reduces secretion activity of the salivary glands and other mucous membranes, controls acidity in gastric secretions, and stabilizes cardiac rhythm by reducing vagal tone during surgical procedures.

Directions:

• Administration: Glycopyrrolate Injection is intended for intravenous or intramuscular use.
  
• Dosage: Administration should be tailored to individual patient needs and the specific surgical conditions. Typically used preoperatively or intraoperatively.
  
• Preparation: Inspect visually for particulate matter and discoloration prior to administration. Only use if the solution is clear and seal remains intact.
  
• Handling Precautions: Dispose of unused portions appropriately. Single-dose vials do not contain preservatives.

Warnings:

• Contraindications: Not to be used in patients with known hypersensitivity to glycopyrrolate or any of its components, glaucoma, or obstructive gastrointestinal tract disease.
  
• Monitoring: Patients should be closely monitored for anticholinergic effects, especially if they have cardiovascular, renal, or hepatic impairments.
  
• Use with Caution: Exercise extreme caution in patients with autonomic neuropathy, ulcerative colitis, and hyperthyroidism.
  
• Pregnancy and Nursing: Use with caution in pregnant or nursing mothers and only if the potential benefit justifies the risk to the fetus or infant.

Side Effects:

• Common Adverse Reactions: Include dry mouth, urinary retention, blurred vision, tachycardia, and constipation.
  
• Serious Reactions: Severe anticholinergic effects such as confusion, hallucinations, and arrhythmias require immediate medical attention.
  
• Reporting: Report any adverse effects or unusual reactions to the prescribing physician for further evaluation and management.

Prepare your medical regime for success with Somerset Pharma’s Glycopyrrolate Injection, ensuring precision and excellence in patient care. Always consult a healthcare professional for personalized medical advice to achieve the best therapeutic outcomes.